Sumati Gupta Selected Research

Lipase (Acid Lipase)

1/2018

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sumati Gupta Research Topics

Disease

21	Neoplasms (Cancer) 04/2024 - 01/2016
8	Carcinoma (Carcinomatosis) 05/2024 - 01/2018
8	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 01/2017
5	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 12/2017
5	Disease Progression 02/2023 - 02/2016
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2016
3	Neoplasm Metastasis (Metastasis) 03/2024 - 08/2021
2	Fatigue 04/2024 - 01/2018
2	Melanoma (Melanoma, Malignant) 10/2023 - 01/2023
2	Hyperphosphatemia 12/2020 - 01/2018
2	Hypertension (High Blood Pressure) 01/2018 - 01/2017
1	Stomach Neoplasms (Stomach Cancer) 10/2023
1	Injection Site Reaction 10/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Nephritis 01/2023
1	Osteoporosis 11/2022
1	Infections 09/2022
1	Urogenital Neoplasms 09/2022
1	Neuroblastoma 02/2018
1	Constipation 01/2018
1	Proteinuria 01/2018
1	Non-Muscle Invasive Bladder Neoplasms 12/2017
1	Hypokalemia 01/2017

Drug/Important Bio-Agent (IBA)

4	PlatinumIBA 04/2024 - 01/2020
4	pembrolizumabIBA 01/2024 - 01/2020
4	infigratinibIBA 01/2022 - 01/2018
3	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2018
3	AndrogensIBA 04/2024 - 08/2021
3	Hormones (Hormone)IBA 03/2024 - 08/2021
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2016
3	avelumabIBA 01/2023 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2020
3	belinostatIBA 01/2019 - 02/2016
2	sacituzumab govitecanIBA 04/2024 - 01/2024
2	Interleukin-15 (Interleukin 15)IBA 10/2023 - 11/2021
2	Monoclonal AntibodiesIBA 10/2023 - 01/2018
2	Axitinib (AG 013736)IBA 01/2023 - 01/2018
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 12/2020
2	LigandsIBA 08/2021 - 01/2018
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 12/2020 - 01/2018
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2019 - 01/2019
2	Histone Deacetylase InhibitorsIBA 01/2019 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2016
1	Complement System Proteins (Complement)IBA 04/2024
1	CreatineIBA 04/2024
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2024
1	Diphosphates (Pyrophosphates)IBA 03/2024
1	Ribose (D-Ribose)IBA 03/2024
1	rucaparibIBA 03/2024
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2024
1	polyadenosineIBA 03/2024
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	spartalizumabIBA 10/2023
1	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 10/2023
1	apatinibIBA 02/2023
1	Sunitinib (Sutent)FDA Link 01/2023
1	cabozantinibIBA 01/2023
1	Zoledronic Acid (Zometa)FDA Link 11/2022
1	Denosumab FDA Link 11/2022
1	VaccinesIBA 09/2022
1	COVID-19 VaccinesIBA 09/2022
1	Diphosphonates (Bisphosphonates)IBA 08/2021
1	Cancer VaccinesIBA 12/2020
1	Radium-223IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2020
1	AcetyltransferasesIBA 01/2019
1	PanobinostatIBA 01/2019
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2019
1	mocetinostatIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	CREB-Binding ProteinIBA 01/2019
1	Lysine (L-Lysine)FDA Link 02/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	Alanine Transaminase (SGPT)IBA 01/2018
1	ChromatinIBA 01/2018
1	CreatinineIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Amylases FDA Link 01/2018
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2018
1	Sucrose (Saccharose)IBA 01/2018
1	IntegrasesIBA 01/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 05/2017
1	Circulating Tumor DNAIBA 05/2017
1	Abiraterone AcetateIBA 01/2017
1	Eplerenone (Inspra)FDA LinkGeneric 01/2017
1	MineralocorticoidsIBA 01/2017
1	abirateroneIBA 01/2017

Therapy/Procedure

21	Therapeutics 05/2024 - 01/2016
8	Castration 04/2024 - 01/2017
4	Drug Therapy (Chemotherapy) 04/2024 - 01/2020
2	Neoadjuvant Therapy 12/2023 - 11/2021
2	Cystectomy 12/2023 - 11/2021
2	Immunotherapy 01/2023 - 12/2020
1	Resistance Training 04/2024
1	Salvage Therapy 01/2022
1	Precision Medicine 12/2017